SCM
VTYX

Sterling Capital Management’s Ventyx Biosciences VTYX Stock Holding History

Sterling Capital Management’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,092
Closed -$1.26K – 3409
2025
Q1 		$1.26K Sell
1,092
-972
-47% -$1.67K ﹤0.01% 2737
2024
Q4 		$4.52K Buy
2,064
+1,871
+969% +$4.24K ﹤0.01% 2506
2024
Q3 		$421 Buy
+193
New +$444 ﹤0.01% 2939

Other funds holding VTYX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Sterling Capital Management's VTYX Position: Q2 2025 in Review

Sterling Capital Management sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 1,092 shares — an estimated $1.26K sold.

Sterling Capital Management first reported a position in VTYX in Q3 2024 and held it in 3 quarters. The position peaked at $4.52K in Q4 2024. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

  • Sterling Capital Management reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
  • Sterling Capital Management sold 1,092 Ventyx Biosciences shares in Q2 2025, an estimated $1.26K.
  • Sterling Capital Management first reported a position in Ventyx Biosciences in Q3 2024 and held it in 3 quarters.
  • Sterling Capital Management's Ventyx Biosciences position peaked at $4.52K in Q4 2024.
  • 114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Sterling Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.